| Literature DB >> 24363685 |
Mohammad Reza Vaez Mahdavi1, Mehrdad Roghani1, Tourandokht Baluchnejadmojarad2.
Abstract
Considering the anti-diabetic potential of Trigonella foenum-graecum (TFG) and its beneficial effect on aortic reactivity of diabetic rats, this study was conducted to evaluate the effect of its alcoholic seed extract on aortic reactivity and also figure out mechanisms including the role of adrenergic and angiotensinergic systems in streptozotocin-diabetic rats. Male Wistar rats were divided into control, extract-treated control, diabetic, and extract-treated diabetic groups. Diabetes was induced by a single IP injection of streptozotocin (STZ; 60 mg/kg). Treatment groups received TFG extract (200 mg/kg; IP) every other day for 1 month. Contractile response of thoracic aorta to KCl and noradrenaline (NA) was then determined. For determination of the involvement of adrenergic and angiotensinergic systems, rings were incubated before the experiments with prazocin, propranolol, and/or captopril and then NA- and angiotensin I (Ag-I)-induced contractions were recorded. Diabetic state significantly increased maximum contractile response to KCl and NA (p < 0.01-0.005) comparing to control groups and treatment with TFG extract in diabetic group significantly improved these changes comparing to untreated diabetic group (p < 0.05-p < 0.01). On the other hand, pretreatment of prazosin and propranolol caused a significant reduction in contractile response of all groups (p < 0.05-0.001) meanwhile was no significant difference among the groups. In addition, pre-incubation with captopril caused a significant reduction in contractile response of TFG-treated diabetic group comparing untreated diabetic group (p < 0.05). Finally we concluded that alcoholic seed extract of TFG could improve some functional indices of the vascular system in diabetic state and angiotensinergic system is partly involved in this response.Entities:
Keywords: Adrenergic; Angiotensinergic; Aorta; Diabetes mellitus; Trigonella foenum-graecum
Year: 2011 PMID: 24363685 PMCID: PMC3869585
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Body weight and serum glucose level of control, diabetic, and TFG extract-treated diabetic rats.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| Control* | 268.3 ± 4.9* | 279.6 ± 5.5 | 138.7 ± 4.8** | 141.3 ± 4.6* |
| Control + TFG | 271.6 ± 4.8* | 254.3 ± 5.1 | 136.2 ± 5.4* | 117.2 ± 5.9* |
| Diabetic* | 274.3 ± 6.4* | 219.8 ± 4.9** | 142.3 ± 4.9* | 389.1 ± 13.7*** |
| Diabetic + TFG | 256.5 ± 5.2* | 237.2 ± 5.2 | 151.7 ± 4.1 | 243.2 ± 10.6**# |
* p < 0.05, ** p < 0.005, *** p < 0.001 (In comparison with control group) # p < 0.01 (In comparison with diabetic group
Figure 1Cumulative concentration-response curves for KCL (A) and NA (B) in endothelium-intact aortic preparations 1 month after the exprement . Contractile responses are expressed as grams of tension per cross sectional area (mm2). Data are shown as means ±SEM. *P<0.05, **P<0.01(Compared to VD) (VC, EC, VD and ED represent vehicle-treated control . extract- treated control , vehicle-treated diabetic, and extract- treated control, dose of 200 mg/kg of the extract)
Figure 2Maximum NA-induced contractile response of endothelium-intact aortic rings different groups 1 month after the experiment in the absence and presence of prazosin propranolol (B). Data are shown as means ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001 (as compared to data before addition of prazosin propranolol (10 nM)).
Figure 3Maximum angiotensin I-induced contractile response of endothelium-intact aortic rings from different groups 1 month after the experiment in the absence and presence of captopril. Data are shown as means ± SEM. *p < 0.01, ** p < 0.005 (relative to data before addition of the captopril); # p < 0.05 (as compared to diabetic group